Patients with advanced bladder cancer treated with an immunosuppressant drug were a third less likely to see the disease ...
A 'game-changer' study found advanced bladder cancer patients treated with the drug durvalumab were a third less likely to ...
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
said the “magnitude of survival benefit seen will certainly be a game changer”. He added: “These are exciting times in the management of muscle-invasive bladder cancer. “We had not seen ...
said the 'magnitude of survival benefit seen will certainly be a game changer'. He added: 'These are exciting times in the management of muscle-invasive bladder cancer. 'We had not seen any ...
said the “magnitude of survival benefit seen will certainly be a game changer”. He added: “These are exciting times in the management of muscle-invasive bladder cancer. “We had not seen ...
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...